Publications by authors named "M Juchaux"

Article Synopsis
  • Proton Minibeam Radiation Therapy (pMBRT) is a unique technique that modulates radiation dose delivery to potentially enhance anti-tumor immune responses while impacting treatment outcomes through specific dosimetric parameters like peak and valley doses.* -
  • The study used an orthotopic rat model of glioblastoma to explore how different pMBRT configurations influence survival and immune response, finding that higher dose heterogeneity and maintaining a minimum valley dose improved overall outcomes.* -
  • Results indicated that optimizing both peak doses and valley doses led to better tumor eradication and less immunosuppression, contrasting with traditional proton therapy that usually creates uniform dose distributions.*
View Article and Find Full Text PDF

The biology underlying proton minibeam radiation therapy (pMBRT) is not fully understood. Here we aim to elucidate the biological effects of pMBRT using Fourier Transform Infrared Microspectroscopy (FTIRM). In vitro (CTX-TNA2 astrocytes and F98 glioma rat cell lines) and in vivo (healthy and F98-bearing Fischer rats) irradiations were conducted, with conventional proton radiotherapy and pMBRT.

View Article and Find Full Text PDF

Purpose: Proton minibeam radiation therapy (pMBRT) is an innovative radiation therapy approach that highly modulates the spatial dimension of the dose delivery using narrow, parallel, and submillimetric proton beamlets. pMBRT has proven its remarkable healthy tissue preservation in the brain and skin. This study assesses the potential advantages of pMBRT for thoracic irradiations compared with conventional radiation therapy in terms of normal tissue toxicity.

View Article and Find Full Text PDF

Background: FLASH-radiotherapy (FLASH-RT) is an emerging modality that uses ultra-high dose rates of radiation to enable curative doses to the tumor while preserving normal tissue. The biological studies showed the potential of FLASH-RT to revolutionize radiotherapy cancer treatments. However, the complex biological basis of FLASH-RT is not fully known yet.

View Article and Find Full Text PDF

Background: Radiation-induced neurocognitive dysfunction is a major adverse effect of brain radiation therapy and has specific relevance in pediatric oncology, where serious cognitive deficits have been reported in survivors of pediatric brain tumors. Moreover, many pediatric patients receive proton therapy under general anesthesia or sedation to guarantee precise ballistics with a high oxygen content for safety. The present study addresses the relevant question of the potential effect of supplemental oxygen administered during anesthesia on normal tissue toxicity and investigates the anti-tumor immune response generated following conventional and FLASH proton therapy.

View Article and Find Full Text PDF